47 individuals, including medical professionals, indicted for inappropriate treatment of newborns leading to deaths in a major health scandal in Turkey.
A recent study published in JAMA compared the effectiveness of two medications, methadone and buprenorphine/naloxone, for treating opioid use disorder, revealing that patients treated with methadone had a lower rate of treatment discontinuation over 24 months.
A recent study revealed that simultaneous parental leave is linked to increased postpartum mental health care utilization for parents in Sweden, with mothers showing increased antidepressant use and fathers having more substance use disorder-related visits.
A systematic analysis of 68 studies and 9,525 participants with schizophrenia spectrum disorders found that no antipsychotic significantly outperformed placebo in improving cognitive function. The analysis concludes that standardizing cognitive assessments in clinical trials could enhance result consistency. (Source: JAMA Psychiatry)
Recent study finds that 84% of adults with congenital heart disease reported good or better quality of life, with notable findings on physical activity and mental health.
Conexiant
Daily News
Stay up to date with the latest clinical headlines.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
Older adults with higher BMI and better diet quality experienced a slower decline in depressive symptoms over a 4-year period, suggesting a potential protective effect.
New study: Maternal COVID-19 exposure in utero not linked to increased risk of neurodevelopmental delays in children through 24 months. Read more in JAMA Network Open.
Research published in BMC Primary Care finds that only 44% of patients with opioid use disorder in primary care settings adhere to their prescribed buprenorphine treatment, with male sex and unexpected positive opioid toxicology results associated with lower adherence.